Prevalence of CYP2C19 Variants in Patients with Cardiovascular Disease from the Yunnan-Guizhou Plateau in Southwestern China
These results represent the first comprehensive profile of <i>CYP2C19</i> variants in patients with cardiovascular disease from the Yunnan-Guizhou Plateau, offering a valuable genetic reference for the selection of optimal treatment strategies.
Authors
- Fei He (ORCID: https://orcid.org/0000-0002-1165-3248)
- Xiang Ma (ORCID: https://orcid.org/0000-0001-6139-4355)
- Chao Yue (ORCID: https://orcid.org/0000-0001-9720-5210)
- Yong Sun (ORCID: https://orcid.org/0000-0002-3648-5308)
- Ting Ji (ORCID: https://orcid.org/0000-0002-9155-8397)
- Zheng-Fu Zhang
- Jianpeng Hu (ORCID: https://orcid.org/0000-0002-6511-6448)
- Hongwei Li (ORCID: https://orcid.org/0000-0002-9892-8370)
- Hongxia Liu (ORCID: https://orcid.org/0000-0002-4384-7776)
- Junling Wang (ORCID: https://orcid.org/0000-0003-3929-6227)
- Qian Xiong (ORCID: https://orcid.org/0009-0003-7867-9017)
- Boyu Chen (ORCID: https://orcid.org/0000-0002-5981-0505)
- Xiaoyu Li
- Shuning LEI
Institutions
- Kunming Medical University (CN)
- Qujing Normal University (CN)
- Dali University (CN)
Publication Details
- Journal
- Pharmacogenomics and Personalized Medicine
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/pgpm.s509794
- Citations
- 2
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.11
Funders
- Kunming Medical University
- Yunnan Provincial Department of Education